<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Pediatric Cancer

Honors    Pediatric Cancer

U.S. News Ranks Colorado Pediatric Oncology Services Ninth in the Nation

U.S. News and World Report (USNWR) released its 2020-21 Best Children’s Hospitals rankings this week. In the category of best hospitals for pediatric cancer, Children’s Hospital Colorado was ranked ninth in the country. Pediatric cancer services are provided by University of Colorado (CU) School of Medicine faculty who many are members of the CU Cancer Center.


Author Cancer Center | Publish Date June 19, 2020
Full Story

CU Cancer Center In the News

OncLive

Dr. Schenk on the Evolving Treatment Landscape in Lung Cancer

news outletOncLive
Publish DateAugust 25, 2020

Erin Schenk, MD, PhD, University of Colorado Cancer Center member, discusses the rapidly evolving treatment landscape in lung cancer.

Full Story
OncLive

Dr. Bunn on Targeting HER3 in NSCLC

news outletOncLive
Publish DateAugust 18, 2020

Paul A. Bunn, Jr, MD, distinguished professor, James Dudley Chair in Lung Cancer Research, Division of Medical Oncology, University of Colorado, and a 2014 Giant of Cancer Care® in Lung Cancer, discusses potentially targeting HER3 in non–small cell lung cancer (NSCLC).

Full Story
Oncology Learning Network

Oral Apixaban Preferable for Preventing Postsurgery VTE in Patients With Gynecologic Cancer

news outletOncology Learning Network
Publish DateAugust 10, 2020

“Current guidelines recommend a 28-day course of enoxaparin for thromboprophylaxis after surgery for gynecologic cancer,” wrote Saketh R. Guntupalli, Director of the Division of Gynecologic Oncology, University of Colorado School of Medicine, and colleagues.

Full Story
OncLive

Dr. Bunn on Data With Trastuzumab Deruxtecan in HER2-Mutant NSCLC

news outletOncLive
Publish DateJuly 27, 2020

Paul A. Bunn, Jr, distinguished professor, James Dudley Chair in Lung Cancer Research, Division of Medical Oncology, University of Colorado and a 2014 Giant of Cancer Care® in Lung Cancer, highlights encouraging data with fam-trastuzumab deruxtecan-nxki (Enhertu) in HER2-mutant non–small cell lung cancer (NSCLC).

Full Story